Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.71 |
| ▸ | P4HB | P07237 | 6/20 | 0.71 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.71 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.71 |
| ▸ | MAOA | P21397 | 4/20 | 0.71 |
| ▸ | XDH | P47989 | 4/20 | 0.71 |
| ▸ | SLCO2B1 | O94956 | 3/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.71 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | CA12 | O43570 | 2/20 | 0.71 |
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | CA4 | P22748 | 2/20 | 0.71 |
| ▸ | CA7 | P43166 | 2/20 | 0.71 |
| ▸ | GAA | P10253 | 5/20 | 0.66 |
| ▸ | MAPT | P10636 | 5/20 | 0.66 |
| ▸ | POLB | P06746 | 4/20 | 0.66 |
| ▸ | ALPI | P09923 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8374228 | 1.00 | KDM4E (0.71) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL6903921 | 0.93 | NQO2 (0.70) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL4650695 | 0.89 | KDM4E (0.70) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL6905094 | 0.88 | MEN1 (0.66) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL17938818 | 0.86 | KDM4E (0.73) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL2510346 | 0.86 | KDM4E (0.73) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL7601750 | 0.86 | KDM4E (0.73) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL25414144 | 0.86 | P4HB (0.83) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL24608 | 0.84 | AKR1B1 (0.74) | KDM4EP4HBAKR1B1EPHX2MAOA | |
| SCHEMBL21408655 | 0.84 | AKR1B1 (0.74) | KDM4EP4HBAKR1B1EPHX2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240261312-A1 | Method and compositions for treating animal viral infections | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-08-08 | — | — | US | claimed |
| EP-4387627-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | Phoenix Biotechnology, Inc. (US) | 2024-06-26 | — | — | EP | claimed |
| EP-3655015-B1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | UNIV COLORADO REGENTS (US) | 2024-02-21 | — | — | EP | claimed |
| EP-4009981-B1 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | PHOENIX BIOTECHNOLOGY INC (US) | 2023-08-16 | — | — | EP | claimed |
| EP-4156947-A1 | EXTRACT CONTAINING OLEANDRIN AND METHOD OF PRODUCTION THEREOF | Phoenix Biotechnology, Inc. (US) | 2023-04-05 | — | — | EP | claimed |
| WO-2023022866-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-02-23 | — | — | WO | claimed |
| US-20220370449-A1 | COMBINED PHARMACEUTICAL COMPOSITION | GIDD COMMERCIAL USA, INC. | 2022-11-24 | — | — | US | claimed |
| US-11406636-B2 | Combined pharmaceutical composition | GIDD COMMERCIAL USA, INC. (US) | 2022-08-09 | — | — | US | claimed |
| EP-4009981-A1 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | Phoenix Biotechnology, Inc. (US) | 2022-06-15 | — | — | EP | claimed |
| WO-2021242590-A1 | EXTRACT CONTAINING OLEANDRIN AND METHOD OF PRODUCTION THEREOF | PHOENIX BIOTECHNOLOGY, INC. (US) | 2021-12-02 | — | — | WO | claimed |
| WO-2021202103-A2 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | PHOENIX BIOTECHNOLOGY, INC. (US) | 2021-10-07 | — | — | WO | claimed |
| WO-2021201903-A1 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | PHOENIX BIOTECHNOLOGY, INC. (US) | 2021-10-07 | — | — | WO | claimed |
| US-10729735-B1 | Method and compostitions for treating coronavirus infection | PHOENIX BIOTECHNOLOGY, INC. (US) | 2020-08-04 | — | — | US | claimed |
| US-20190183892-A1 | COMBINED PHARMACEUTICAL COMPOSITION | GIDD COMMERCIAL USA, INC. | 2019-06-20 | — | — | US | claimed |
| US-20040162247-A1 | Therapeutic agent or osteoporosis comprising an active ingredient of quercetin derivatives | KIM CHUNG-SOOK (KR) | 2004-08-19 | — | — | US | claimed |
| EP-1309326-A1 | A THERAPEUTIC AGENT OF OSTEOPOROSIS COMPRISING AN ACTIVE INGREDIENT OF QUERCETIN DERIVATIVES | Korea Institute of Oriental Medicine (KR) | 2003-05-14 | — | — | EP | claimed |
| US-20020165169-A1 | Therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives | KOREA INSTITUTE OF ORIENTAL MEDICINE (KR) | 2002-11-07 | — | — | US | claimed |
| WO-2002017909-A1 | A THERAPEUTIC AGENT OF OSTEOPOROSIS COMPRISING AN ACTIVE INGREDIENT OF QUERCETIN DERIVATIVES | KOREA INSTITUTE OF ORIENTAL MEDICINE (KR) | 2002-03-07 | — | — | WO | claimed |
| EP-0275005-B1 | COMPLEX COMPOUNDS OF BIOFLAVONOIDS WITH PHOSPHOLIPIDS, THEIR PREPARATION AND USE, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM | INDENA S.p.A. (IT) | 1993-08-11 | — | — | EP | claimed |
| US-12447142-B2 | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250275926-A1 | MULTILAYER FORMULATION COMPRISING MODIFIED TAPIOCA STARCH FOR CONTROLLED-RELEASE OF ACTIVE AGENTS | ACCESS BUSINESS GROUP INT LLC (US) | 2025-09-04 | — | — | US | disclosed |
| EP-3827675-B1 | TOBACCO MATERIAL PRODUCTION METHOD, TOBACCO MATERIAL, TOBACCO FLAVOR LIQUID PRODUCTION METHOD, TOBACCO FLAVOR LIQUID, AND HEATING-TYPE FLAVOR INHALER | JAPAN TOBACCO INC (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-20240415095-A1 | PET HEALTH AQUEOUS COMPOSITION AND ASSOCIATED CONTAINER | SUSU PETS LLC (US) | 2024-12-19 | — | — | US | disclosed |
| US-12097234-B2 | Extract containing oleandrin and method of production thereof | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-09-24 | — | — | US | disclosed |
| US-20240261312-A1 | Method and compositions for treating animal viral infections | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-08-08 | — | — | US | disclosed |
| US-20240245741-A1 | EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL | MINASOLVE SAS (FR) | 2024-07-25 | — | — | US | disclosed |
| EP-4401852-A1 | EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL | Minasolve SAS (FR) | 2024-07-24 | — | — | EP | disclosed |
| EP-4387627-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | Phoenix Biotechnology, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-3655015-B1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | UNIV COLORADO REGENTS (US) | 2024-02-21 | — | — | EP | disclosed |
| EP-4295854-A2 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | Phoenix Biotechnology, Inc. (US) | 2023-12-27 | — | — | EP | disclosed |
| WO-2023235807-A2 | METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMA WITH TRITERPENES | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-11806359-B2 | Method and compositions for treating Coronavirus infection | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-11-07 | — | — | US | disclosed |
| WO-2023205222-A1 | MULTILAYER FORMULATION COMPRISING MODIFIED TAPIOCA STARCH FOR CONTROLLED-RELEASE OF ACTIVE AGENTS | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2023-10-26 | — | — | WO | disclosed |
| EP-4009981-B1 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | PHOENIX BIOTECHNOLOGY INC (US) | 2023-08-16 | — | — | EP | disclosed |
| US-20230233517-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | TSINGHUA UNIVERSITY (CN) | 2023-07-27 | — | — | US | disclosed |
| US-20230158093-A1 | Extract containing oleandrin and method of production thereof | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| EP-4156947-A1 | EXTRACT CONTAINING OLEANDRIN AND METHOD OF PRODUCTION THEREOF | Phoenix Biotechnology, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| WO-2023036973-A1 | EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL | MINASOLVE SAS (FR) | 2023-03-16 | — | — | WO | disclosed |
| WO-2023022866-A1 | METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS | PHOENIX BIOTECHNOLOGY, INC. (US) | 2023-02-23 | — | — | WO | disclosed |
| US-20220369592-A1 | Container for an Aqueous Composition | SUSU PETS, LLC (US) | 2022-11-24 | — | — | US | disclosed |
| US-20220370449-A1 | COMBINED PHARMACEUTICAL COMPOSITION | GIDD COMMERCIAL USA, INC. | 2022-11-24 | — | — | US | disclosed |
| US-20220362275-A1 | Method and Compositions for Treating Glioblastoma | PHOENIX BIOTECHNOLOGY, INC. (US) | 2022-11-17 | — | — | US | disclosed |
| US-11452709-B2 | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-09-27 | — | — | US | disclosed |
| US-11406636-B2 | Combined pharmaceutical composition | GIDD COMMERCIAL USA, INC. (US) | 2022-08-09 | — | — | US | disclosed |
| EP-4009981-A1 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | Phoenix Biotechnology, Inc. (US) | 2022-06-15 | — | — | EP | disclosed |
| US-20220160741-A1 | Method and Compositions for Treating Coronavirus Infection | PHOENIX BIOTECHNOLOGY, INC. (US) | 2022-05-26 | — | — | US | disclosed |
| US-11298330-B2 | Magnesium compositions and methods of use | NEUROCENTRIA, INC. (US) | 2022-04-12 | — | — | US | disclosed |
| US-20220054521-A1 | Method and Compositions for Treating Coronavirus Infection | PHOENIX BIOTECHNOLOGY, INC. (US) | 2022-02-24 | — | — | US | disclosed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
| WO-2021242590-A1 | EXTRACT CONTAINING OLEANDRIN AND METHOD OF PRODUCTION THEREOF | PHOENIX BIOTECHNOLOGY, INC. (US) | 2021-12-02 | — | — | WO | disclosed |
| WO-2021202103-A2 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | PHOENIX BIOTECHNOLOGY, INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021201903-A1 | METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION | PHOENIX BIOTECHNOLOGY, INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| US-11134634-B2 | Flower pigmentation in pelargonium hortorum | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-05 | — | — | US | disclosed |
| WO-2021113027-A1 | METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMA | PHOENIX BIOTECHNOLOGY, INC. (US) | 2021-06-10 | — | — | WO | disclosed |
| EP-3827675-A1 | TOBACCO MATERIAL PRODUCTION METHOD, TOBACCO MATERIAL, TOBACCO FLAVOR LIQUID PRODUCTION METHOD, TOBACCO FLAVOR LIQUID, AND HEATING-TYPE FLAVOR INHALER | Japan Tobacco Inc. (JP) | 2021-06-02 | — | — | EP | disclosed |
| EP-3562472-B1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2021-05-19 | — | — | EP | disclosed |
| US-10981084-B2 | Use of coconut water as extraction solvent | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2021-04-20 | — | — | US | disclosed |
| US-20200396961-A1 | CONTAINER FOR AN AQUEOUS COMPOSITION | SUSU PETS LLC (US) | 2020-12-24 | — | — | US | disclosed |
| WO-2020257438-A1 | A CONTAINER FOR AN AQUEOUS COMPOSITION | SUSU PETS, LLC (US) | 2020-12-24 | — | — | WO | disclosed |
| US-10729735-B1 | Method and compostitions for treating coronavirus infection | PHOENIX BIOTECHNOLOGY, INC. (US) | 2020-08-04 | — | — | US | disclosed |
| EP-3655015-A2 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | The Regents of the University of Colorado (US) | 2020-05-27 | — | — | EP | disclosed |
| US-20200155502-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2020-05-21 | — | — | US | disclosed |
| US-20200121624-A1 | MAGNESIUM COMPOSITIONS AND METHODS OF USE | NEUROCENTRIA, INC. | 2020-04-23 | — | — | US | disclosed |
| US-20190336884-A1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2019-11-07 | — | — | US | disclosed |
| EP-3562472-A1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF Beauty Care Solutions France SAS (FR) | 2019-11-06 | — | — | EP | disclosed |
| EP-2545896-B1 | Sunscreen compositions | HENKEL AG & CO KGAA (DE) | 2019-10-16 | — | — | EP | disclosed |
| US-20190183892-A1 | COMBINED PHARMACEUTICAL COMPOSITION | GIDD COMMERCIAL USA, INC. | 2019-06-20 | — | — | US | disclosed |
| WO-2019018451-A2 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2019-01-24 | — | — | WO | disclosed |
| WO-2018200885-A1 | MAGNESIUM COMPOSITIONS AND METHODS OF USE | NEUROCENTRIA, INC. (US) | 2018-11-01 | — | — | WO | disclosed |
| US-20180235168-A1 | FLOWER PIGMENTATION IN PELARGONIUM HORTORUM | SYNGENTA PARTICIPATIONS AG (CH) | 2018-08-23 | — | — | US | disclosed |
| EP-2545900-B1 | Sun screen compounds with high sun block factor and pleasant feel | HENKEL AG & CO KGAA (DE) | 2018-08-08 | — | — | EP | disclosed |
| WO-2018122514-A1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2018-07-05 | — | — | WO | disclosed |
| EP-2545901-B1 | Emulsion base for sun screen compounds | HENKEL AG & CO KGAA (DE) | 2017-11-22 | — | — | EP | disclosed |
| EP-2370177-B1 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | HENKEL AG & CO KGAA (DE) | 2017-11-15 | — | — | EP | disclosed |
| EP-2858641-B1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORP (US) | 2017-09-06 | — | — | EP | disclosed |
| EP-2774600-B1 | Lamellar oil-water emulsions with multilayer pigment capsules | HENKEL AG & CO KGAA (DE) | 2017-04-05 | — | — | EP | disclosed |
| EP-1938784-B1 | Pre-treatment agent for protecting the scalp | HENKEL AG & CO KGAA (DE) | 2017-02-08 | — | — | EP | disclosed |
| EP-2349182-B1 | FOAMING EMULSIONS | HENKEL AG & CO KGAA (DE) | 2017-01-04 | — | — | EP | disclosed |
| EP-1852102-B1 | Method for manufacturing oil in water emulsions for roll-on applications | HENKEL AG & CO KGAA (DE) | 2016-10-05 | — | — | EP | disclosed |
| CN-105688982-A | Bioactive catalyst enabling alcohol-water system to produce hydrogen through reforming | 广西三久新能科技有限公司 | 2016-06-22 | — | — | CN | disclosed |
| EP-1803435-B1 | Cosmetic sun protection compositions based on lamelliform emulsions | HENKEL AG & CO KGAA (DE) | 2016-06-08 | — | — | EP | disclosed |
| EP-2633887-B1 | Novel agent combination for efficient anti-wrinkle effect | HENKEL AG&CO KGAA (DE) | 2016-03-02 | — | — | EP | disclosed |
| EP-2023888-B1 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | HENKEL AG & CO KGAA (DE) | 2015-10-07 | — | — | EP | disclosed |
| EP-2878341-A2 | Application of cosmetic compositions for the inactivation and/or elimination of skin mites | Henkel AG & Co. KGaA (DE) | 2015-06-03 | — | — | EP | disclosed |
| EP-2878292-A2 | Application of cosmetic compositions for the inactivation and/or elimination of skin mites | Henkel AG & Co. KGaA (DE) | 2015-06-03 | — | — | EP | disclosed |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2015-05-21 | — | — | US | disclosed |
| EP-2858641-A1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF Corporation (US) | 2015-04-15 | — | — | EP | disclosed |
| US-20150064285-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | MAGCEUTICS, INC. (US) | 2015-03-05 | — | — | US | disclosed |
| EP-2774600-A2 | Lamellar oil-water emulsions with multilayer pigment capsules | Henkel AG & Co. KGaA (DE) | 2014-09-10 | — | — | EP | disclosed |
| WO-2014083438-A2 | NITRIC OXIDE INCREASING NUTRITIONAL SUPPLEMENTS AND METHODS | Abattis Bioceuticals Corp (CA) | 2014-06-05 | — | — | WO | disclosed |
| US-8734855-B2 | Slow release magnesium composition and uses thereof | MAGCEUTICS, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| WO-2013184884-A1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORPORATION (US) | 2013-12-12 | — | — | WO | disclosed |
| US-20130236542-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | MAGCEUTICS, INC. (US) | 2013-09-12 | — | — | US | disclosed |
| EP-2633887-A1 | Novel agent combination for efficient anti-wrinkle effect | Henkel AG&Co. KGAA (DE) | 2013-09-04 | — | — | EP | disclosed |
| EP-2628479-A1 | Cosmetic use of climbazol | Henkel AG&Co. KGAA (DE) | 2013-08-21 | — | — | EP | disclosed |
| WO-2013091975-A1 | BIOMIMETIC COMPOSITIONS FOR SKIN CLEANSING AND SKIN CARE | HENKEL AG & CO. KGAA (DE) | 2013-06-27 | — | — | WO | disclosed |
| EP-2601931-A2 | Cosmetic use of 3-methyl-1-phenyl-5-pyrazolon | Henkel AG&Co. KGAA (DE) | 2013-06-12 | — | — | EP | disclosed |
| EP-2591767-A2 | Skin-firming cosmetic compositions with pleasant feeling on use | Henkel AG & Co. KGaA (DE) | 2013-05-15 | — | — | EP | disclosed |
| US-8377473-B2 | Slow release magnesium composition and uses thereof | MAGCEUTICS, INC. (US) | 2013-02-19 | — | — | US | disclosed |
| EP-2545901-A2 | Emulsion base for sun screen compounds | Henkel AG & Co. KGaA (DE) | 2013-01-16 | — | — | EP | disclosed |
| EP-2545896-A2 | Sunscreen compositions | Henkel AG & Co. KGaA (DE) | 2013-01-16 | — | — | EP | disclosed |
| EP-2545900-A2 | Sun screen compounds with high sun block factor and pleasant feel | Henkel AG & Co. KGaA (DE) | 2013-01-16 | — | — | EP | disclosed |
| EP-2514401-A2 | Cosmetic and dermatological compounds for dry skin | Henkel AG & Co. KGaA (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2451434-A2 | ACTIVE-INGREDIENT COMBINATION FOR TREATING MATURE SKIN II | Henkel AG & Co. KGaA (DE) | 2012-05-16 | — | — | EP | disclosed |
| EP-2448413-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | Magceutics, Inc. (US) | 2012-05-09 | — | — | EP | disclosed |
| EP-2097059-B1 | CLEANSING OR CARE PRODUCT | HENKEL KGAA (DE) | 2012-04-18 | — | — | EP | disclosed |
| US-8084674-B2 | Flower pigmentation in Pelargonium hortorum | SYNGENTA PARTICIPATIONS AG (CH) | 2011-12-27 | — | — | US | disclosed |
| EP-2370177-A2 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | Henkel AG & Co. KGaA (DE) | 2011-10-05 | — | — | EP | disclosed |
| EP-2349183-A2 | FOAMING EMULSIONS CONTAINING POLYMERS | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2349181-A1 | FOAMING EMULSIONS COMPRISING A COMBINATION OF EMULSIFIERS | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2349182-A2 | FOAMING EMULSIONS | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2346487-A2 | ACTIVE INGREDIENT COMBINATION FOR THE TREATMENT OF MATURE SKIN I | Henkel AG & Co. KGaA (DE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2011079971-A2 | COSMETICS CONTAINING EUK-134 AND/OR EUK-118 AND AT LEAST ONE COSMETIC CARE SUBSTANCE | HENKEL AG & CO. KGAA (DE) | 2011-07-07 | — | — | WO | disclosed |
| US-20110097288-A1 | Sun Protection Composition | HENKEL AG & CO. KGAA (DE) | 2011-04-28 | — | — | US | disclosed |
| US-20110041198-A1 | FLOWER PIGMENTATION IN PELARGONIUM HORTORUM | SYNGENTA PARTICIPATIONS AG | 2011-02-17 | — | — | US | disclosed |
| US-20110020443-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | MAGCEUTICS, INC. (US) | 2011-01-27 | — | — | US | disclosed |
| WO-2011003045-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | MAGCEUTICS, INC. (US) | 2011-01-06 | — | — | WO | disclosed |
| EP-2266529-A2 | UV protection cosmetic product | Henkel AG & Co. KGaA (DE) | 2010-12-29 | — | — | EP | disclosed |
| EP-2266527-A2 | Sun screen compositions with improved antioxidant potential | Henkel AG & Co. KGaA (DE) | 2010-12-29 | — | — | EP | disclosed |
| EP-2241353-A2 | Foaming emulsions with polymers | Henkel AG & Co. KGaA (DE) | 2010-10-20 | — | — | EP | disclosed |
| EP-2238964-A2 | Stabilised cosmetic compounds | Henkel AG & Co. KGaA (DE) | 2010-10-13 | — | — | EP | disclosed |
| EP-2223679-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2010-09-01 | — | — | EP | disclosed |
| EP-2219432-A1 | FLOWER PIGMENTATION IN PELARGONIUM HORTORUM | Goldsmith Seeds Inc. (US) | 2010-08-25 | — | — | EP | disclosed |
| EP-2201928-A2 | Sun screen compounds | Henkel AG & Co. KGaA (DE) | 2010-06-30 | — | — | EP | disclosed |
| EP-2201927-A2 | Sun screen compounds | Henkel AG & Co. KGaA (DE) | 2010-06-30 | — | — | EP | disclosed |
| EP-2201929-A2 | Sun screen compounds | Henkel AG & Co. KGaA (DE) | 2010-06-30 | — | — | EP | disclosed |
| WO-2010063673-A2 | NOVEL COSMETIC COMPOSITIONS HAVING HAIR GROWTH INHIBITING EFFECT | HENKEL AG & CO. KGAA (DE) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010060895-A2 | FOAMING EMULSIONS CONTAINING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010060894-A2 | FOAMING EMULSIONS | HENKEL AG & CO. KGAA (DE) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010060896-A1 | FOAMING EMULSIONS COMPRISING A COMBINATION OF EMULSIFIERS | HENKEL AG & CO. KGAA (DE) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010049011-A2 | ACTIVE-INGREDIENT COMBINATION FOR TREATING MATURE SKIN II | HENKEL AG & CO. KGAA (DE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049457-A2 | ACTIVE INGREDIENT COMBINATION FOR THE TREATMENT OF MATURE SKIN I | HENKEL AG & CO. KGAA (DE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049389-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS FOR THE THREE-DIMENSIONAL REDUCTION OF WRINKLES | HENKEL AG & CO. KGAA (DE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049390-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS FOR THE REDUCTION OF FACIAL EXPRESSION WRINKLES | HENKEL AG & CO. KGAA (DE) | 2010-05-06 | — | — | WO | disclosed |
| EP-2167018-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION | Henkel AG & Co. KGaA (DE) | 2010-03-31 | — | — | EP | disclosed |
| EP-2167017-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION HAVING A HYDROGEL FORMER | Henkel AG & Co. KGaA (DE) | 2010-03-31 | — | — | EP | disclosed |
| US-20100047296-A1 | Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III | HENKEL AG & CO. KGAA (DE) | 2010-02-25 | — | — | US | disclosed |
| EP-2127633-A1 | Sun screen compounds | Henkel AG & Co. KGaA (DE) | 2009-12-02 | — | — | EP | disclosed |
| EP-2097059-A1 | CLEANSING OR CARE PRODUCT | Henkel Kommanditgesellschaft auf Aktien (DE) | 2009-09-09 | — | — | EP | disclosed |
| EP-2076235-A2 | LOW-RESIDUE COSMETIC OR DERMATOLOGICAL STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION III | Henkel AG & Co. KGaA (DE) | 2009-07-08 | — | — | EP | disclosed |
| WO-2009064451-A1 | FLOWER PIGMENTATION IN PELARGONIUM HORTORUM | GOLDSMITH SEEDS INC. (US) | 2009-05-22 | — | — | WO | disclosed |
| US-20090133151-A1 | Flower Pigmentation in Pelargonium hortorum | SYNGENTA CROP PROTECTION AG (CH) | 2009-05-21 | — | — | US | disclosed |
| EP-1671673-B1 | Pigments containing water-in-siliconoil-emulsion for improving the appearance of the skin | HENKEL AG & CO KGAA (DE) | 2009-04-22 | — | — | EP | disclosed |
| US-20090047226-A1 | Quick-drying cosmetic emulsions for roll-on application | HENKEL AG & C. KGAA (DE) | 2009-02-19 | — | — | US | disclosed |
| EP-2023888-A2 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | Henkel AG & Co. KGaA (DE) | 2009-02-18 | — | — | EP | disclosed |
| EP-2011476-A2 | Moisture-emitting cosmetic and dermatological compounds with enhancers | Henkel AG & Co. KGaA (DE) | 2009-01-07 | — | — | EP | disclosed |
| WO-2008155382-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION HAVING A HYDROGEL FORMER | HENKEL AG & CO. KGAA (DE) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008155391-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION | HENKEL AG & CO. KGAA (DE) | 2008-12-24 | — | — | WO | disclosed |
| EP-2005941-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2008-12-24 | — | — | EP | disclosed |
| EP-1994923-A2 | Cosmetic and dermatological compositions for dry skin | Henkel AG & Co. KGaA (DE) | 2008-11-26 | — | — | EP | disclosed |
| EP-1949887-A2 | Cosmetic formulas for skin smoothing and tautening | Henkel AG & Co. KGaA (DE) | 2008-07-30 | — | — | EP | disclosed |
| EP-1943013-A1 | OIL- N-WATER EMULSIONS | Henkel AG & Co. KGaA (DE) | 2008-07-16 | — | — | EP | disclosed |
| EP-1938784-A2 | Pre-treatment agent for protecting the scalp | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | disclosed |
| EP-1938789-A1 | Improvement of the skin friendliness of hyperemizing agents | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | disclosed |
| EP-1938785-A2 | Cosmetic and dermatological oil-in-water emulsions with self-preserving attributes | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | disclosed |
| EP-1932513-A2 | Compounds for improving the visual appearance of the skin | Henkel AG & Co. KGaA (DE) | 2008-06-18 | — | — | EP | disclosed |
| WO-2008065072-A1 | CLEANSING OR CARE PRODUCT | HENKEL AG & CO. KGAA (DE) | 2008-06-05 | — | — | WO | disclosed |
| WO-2008058943-A2 | LOW-RESIDUE COSMETIC OR DERMATOLOGICAL STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION III | HENKEL AG & CO. KGAA (DE) | 2008-05-22 | — | — | WO | disclosed |
| EP-1913929-A2 | Eudermic W/O emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1913932-A2 | Eudermic W/O emulsion | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1913930-A2 | Eudermic W/O emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1902704-A1 | Cosmetic compositions containing a combination of silicon-elastomers | Henkel KGaA (DE) | 2008-03-26 | — | — | EP | disclosed |
| EP-1894994-A1 | Two or more phase face cleansing agent with improved reversible mixing and demixing solution | Henkel KGaA (DE) | 2008-03-05 | — | — | EP | disclosed |
| US-20080050398-A1 | Composition Comprising Beta-Defensin 2 | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2008-02-28 | — | — | US | disclosed |
| WO-2008021210-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | COMBINATORX, INCORPORATED (US) | 2008-02-21 | — | — | WO | disclosed |
| US-20080044390-A1 | Methods and compositions for the treatment of neurodegenerative disorders | CHDI, INCORPORATED | 2008-02-21 | — | — | US | disclosed |
| EP-1880705-A2 | Brightening and/or colouring composition with improved product sensation | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-01-23 | — | — | EP | disclosed |
| US-7294330-B2 | prevent decomposition of steroid ester; inhibit odors | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-11-13 | — | — | US | disclosed |
| WO-2007124889-A2 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | HENKEL AG & CO. KGAA (DE) | 2007-11-08 | — | — | WO | disclosed |
| EP-1852102-A2 | Method for manufacturing oil in water emulsions for roll-on applications | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-11-07 | — | — | EP | disclosed |
| EP-1842573-A2 | Brightening and/or colouring agent with improved product sensation | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-10-10 | — | — | EP | disclosed |
| EP-1815843-A2 | Synergistic protein hydrolysate combinations for treating mature skin | Henkel KGaA (DE) | 2007-08-08 | — | — | EP | disclosed |
| EP-1813310-A2 | Cosmetic stick based on an oil in water dispersion/emulsion | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1812121-A1 | COSMETIC AND DERMATOLOGICAL PREPARATIONS FOR THE TREATMENT OF MATURE SKIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1813252-A1 | Cosmetic composition for matting the scalp | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1803435-A2 | Cosmetic sun protection compositions based on lamelliform emulsions | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-07-04 | — | — | EP | disclosed |
| EP-1800119-A2 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES FOR IMPROVING SENSORY PERCEPTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-06-27 | — | — | EP | disclosed |
| EP-1799311-A2 | COMPOSITIONS WITH INHIBITORS OF THE SYNTHESIS OF PROSTAGLANDIN AND/OR OF LEUKOTRIENE IN CONJUNCTION WITH STIMULATORS OF THE RELEASE OF CUTANEOUS NEUROMEDIATORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-06-27 | — | — | EP | disclosed |
| EP-1790330-A2 | Cosmetic and dermatological compositions containing oligopeptides and apple extract | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-05-30 | — | — | EP | disclosed |
| EP-1790328-A1 | Cosmetic compositions comprising anionic detergents and ionic liquids | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-05-30 | — | — | EP | disclosed |
| WO-2007051528-A1 | OIL-ΙN-WATER EMULSIONS | HENKEL AG & CO. KGAA (DE) | 2007-05-10 | — | — | WO | disclosed |
| EP-1226827-B1 | PHARMACEUTICAL COMPOSITION COMPRISING RUTIN AND LESPEDEZA CAPITATA EXTRACT FOR TREATING OEDEMA | ROEDER 1956 FARMACEUTICI S P A (IT) | 2007-05-02 | — | — | EP | disclosed |
| EP-1776084-A1 | COSMETIC COMPOSITIONS FOR TREATING STRESSED SKIN CONTAINING TAURINE AND LONG-CHAINED FATTY ALCOHOLS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-04-25 | — | — | EP | disclosed |
| EP-1776087-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS COMPRISING (2-HYDROXYETHYL)UREA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-04-25 | — | — | EP | disclosed |
| EP-1349533-B1 | PROPELLANT-GAS-FREE SPRAY PREPARATIONS | HENKEL KGAA (DE) | 2006-08-30 | — | — | EP | disclosed |
| EP-1671673-A1 | Pigments containing water-in-siliconoil-emulsion for improving the appearance of the skin | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-06-21 | — | — | EP | disclosed |
| EP-1661601-A2 | Oil in water emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-05-31 | — | — | EP | disclosed |
| EP-1661602-A2 | Oil in water emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-05-31 | — | — | EP | disclosed |
| WO-2006053688-A1 | COSMETIC AND DERMATOLOGICAL PREPARATIONS FOR THE TREATMENT OF MATURE SKIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006042625-A2 | COMPOSITIONS WITH INHIBITORS OF THE SYNTHESIS OF PROSTAGLANDIN AND/OR OF LEUKOTRIENE IN CONJUNCTION WITH STIMULATORS OF THE RELEASE OF CUTANEOUS NEUROMEDIATORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-04-27 | — | — | WO | disclosed |
| WO-2006042627-A2 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES FOR IMPROVING SENSORY PERCEPTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-04-27 | — | — | WO | disclosed |
| EP-1640041-A2 | Cosmetic and dermatological composition for the treatment of aging or photodamaged skin | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-29 | — | — | EP | disclosed |
| EP-1634576-A1 | DNA repair enzymes and oligopeptides containing cosmetic and dermatological compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-15 | — | — | EP | disclosed |
| WO-2006018149-A1 | COSMETIC COMPOSITIONS FOR TREATING STRESSED SKIN CONTAINING TAURINE AND LONG-CHAINED FATTY ALCOHOLS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | WO | disclosed |
| WO-2006018198-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS COMPRISING (2-HYDROXYETHYL)UREA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | WO | disclosed |
| US-20060008542-A1 | Preparation containing a mixture of picrorrhiza and ginkgo for the relief of disease | LARKINS NICHOLAS J | 2006-01-12 | — | — | US | disclosed |
| EP-1496921-A1 | PREPARATION CONTAINING A MIXTURE OF PICRORRHIZA AND GINKGO FOR THE RELIEF OF DISEASE | Larkins, Nicholas John (GB) | 2005-01-19 | — | — | EP | disclosed |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-11-25 | — | — | US | disclosed |
| US-20040162247-A1 | Therapeutic agent or osteoporosis comprising an active ingredient of quercetin derivatives | KIM CHUNG-SOOK (KR) | 2004-08-19 | — | — | US | disclosed |
| EP-1441691-A2 | BETA-GLUCURONIDASE INHIBITORS FOR USE IN DEODORANTS AND ANTIPERSPIRANTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-08-04 | — | — | EP | disclosed |
| EP-1430882-A2 | Combinations of antioxidants containing 6,7-disubstituted 2,2-dialkylchromanes or -chromenes | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | disclosed |
| EP-1430933-A2 | Cosmetic and pharmaceutical compositions comprising steroid sulfatase inhibitors and their use for the reduction of hair loss | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | disclosed |
| EP-1430879-A2 | Arylsulfatase inhibitors in deodorants and antiperspirants | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | disclosed |
| EP-1428520-A2 | Lipase inhibitors in deodorants and antiperspirants | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-16 | — | — | EP | disclosed |
| EP-1393518-A2 | ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-03-03 | — | — | EP | disclosed |
| WO-2003090769-A1 | PREPARATION CONTAINING A MIXTURE OF PICRORRHIZA AND GINKGO FOR THE RELIEF OF DISEASE | LARKINS NICHOLAS JOHN (GB) | 2003-11-06 | — | — | WO | disclosed |
| EP-1349533-A2 | PROPELLANT-GAS-FREE SPRAY PREPARATIONS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-10-08 | — | — | EP | disclosed |
| WO-2003039505-A2 | ss-GLUCURONIDASE INHIBITORS FOR USE IN DEODORANTS AND ANTIPERSPIRANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-05-15 | — | — | WO | disclosed |
| EP-1309326-A1 | A THERAPEUTIC AGENT OF OSTEOPOROSIS COMPRISING AN ACTIVE INGREDIENT OF QUERCETIN DERIVATIVES | Korea Institute of Oriental Medicine (KR) | 2003-05-14 | — | — | EP | disclosed |
| US-20020165169-A1 | Therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives | KOREA INSTITUTE OF ORIENTAL MEDICINE (KR) | 2002-11-07 | — | — | US | disclosed |
| EP-0630403-B1 | METHODS FOR THE REGULATION OF PLANT FERTILITY | UNIV WASHINGTON (US) | 2002-10-30 | — | — | EP | disclosed |
| WO-2002041848-A2 | PROPELLANT-GAS-FREE SPRAY PREPARATIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-05-30 | — | — | WO | disclosed |
| WO-2002017909-A1 | A THERAPEUTIC AGENT OF OSTEOPOROSIS COMPRISING AN ACTIVE INGREDIENT OF QUERCETIN DERIVATIVES | KOREA INSTITUTE OF ORIENTAL MEDICINE (KR) | 2002-03-07 | — | — | WO | disclosed |
| WO-2001099376-A2 | ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | disclosed |
| EP-0577143-B1 | Solid and liquid solutions of flavonoids | ALFATEC PHARMA GMBH (DE) | 1999-01-27 | — | — | EP | disclosed |
| US-5850014-A | Nucleotide sequences mediating ferility and method of using same | PIONEER HI-BRED INTERNATIONAL (US) | 1998-12-15 | — | — | US | disclosed |
| US-5733759-A | FLAVONOLS AT POLLEN SITES | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-03-31 | — | — | US | disclosed |
| EP-0630403-A4 | METHODS FOR THE REGULATION OF PLANT FERTILITY. | UNIV WASHINGTON (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0630403-A1 | METHODS FOR THE REGULATION OF PLANT FERTILITY | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1994-12-28 | — | — | EP | disclosed |
| EP-0577143-A2 | Solid and liquid solutions of flavonoids | ALFATEC-PHARMA GmbH (DE) | 1994-01-05 | — | — | EP | disclosed |
| WO-1993018142-A1 | METHODS FOR THE REGULATION OF PLANT FERTILITY | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1993-09-16 | — | — | WO | disclosed |
| WO-1993018142-A1 | METHODS FOR THE REGULATION OF PLANT FERTILITY | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1993-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (20 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | KDM4E 4367/4885P4HB 3427/4885AKR1B1 2466/4885 |
| US-12447142-B2 | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy | CTSE, CTSB, ATG4B | KDM4E 157/4885P4HB 3147/4885AKR1B1 2109/4885 |
| US-11452709-B2 | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy | CTSE, CTSB, ATG4B | KDM4E 157/4885P4HB 3147/4885AKR1B1 2109/4885 |
| US-20200121624-A1 | MAGNESIUM COMPOSITIONS AND METHODS OF USE | SLC5A6, SLC6A6, SLC6A5 | KDM4E 4247/4885P4HB 2302/4885AKR1B1 1325/4885 |
| US-20250275926-A1 | MULTILAYER FORMULATION COMPRISING MODIFIED TAPIOCA STARCH FOR CONTROLLED-RELEASE OF ACTIVE AGENTS | SI, AMY1A, GANC | KDM4E 4619/4885P4HB 3158/4885AKR1B1 1567/4885 |
| US-20230233517-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | CTSE, CTSB, ATG4B | KDM4E 157/4885P4HB 3147/4885AKR1B1 2109/4885 |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | GUSB, PON1, IDUA | KDM4E 3145/4885P4HB 537/4885AKR1B1 847/4885 |
| US-20090047226-A1 | Quick-drying cosmetic emulsions for roll-on application | CUTA, UGCG, MGLL | KDM4E 3383/4885P4HB 4328/4885AKR1B1 1991/4885 |
| US-20110020443-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | SLC6A6, COG6, SLC5A6 | KDM4E 4185/4885P4HB 3513/4885AKR1B1 2370/4885 |
| US-20150064285-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | SLC6A6, COG6, SLC5A6 | KDM4E 4185/4885P4HB 3513/4885AKR1B1 2370/4885 |
| US-20040162247-A1 | Therapeutic agent or osteoporosis comprising an active ingredient of quercetin derivatives | NFATC1, MKI67, SOST | KDM4E 952/4885P4HB 4851/4885AKR1B1 836/4885 |
| US-20020165169-A1 | Therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives | NFATC1, MKI67, SOST | KDM4E 893/4885P4HB 4848/4885AKR1B1 776/4885 |
| US-20130236542-A1 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF | SLC6A6, COG6, SLC5A6 | KDM4E 4185/4885P4HB 3513/4885AKR1B1 2370/4885 |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | ALG1, ALG8, CUTA | KDM4E 4367/4885P4HB 3427/4885AKR1B1 2466/4885 |
| US-20100047296-A1 | Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III | TYR, POLR1C, CUTA | KDM4E 2435/4885P4HB 4229/4885AKR1B1 2129/4885 |
| US-11298330-B2 | Magnesium compositions and methods of use | SLC5A6, SLC6A6, SLC6A5 | KDM4E 4247/4885P4HB 2302/4885AKR1B1 1325/4885 |
| US-20080050398-A1 | Composition Comprising Beta-Defensin 2 | DLK1, DSG1, DBNL | KDM4E 4858/4885P4HB 909/4885AKR1B1 4378/4885 |
| US-20200155502-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | CTSE, CTSB, ATG4B | KDM4E 157/4885P4HB 3147/4885AKR1B1 2109/4885 |
| US-20110097288-A1 | Sun Protection Composition | MGLL, DAGLA, ERCC4 | KDM4E 585/4885P4HB 670/4885AKR1B1 3215/4885 |
| US-20080044390-A1 | Methods and compositions for the treatment of neurodegenerative disorders | HTT, SNCA, NLN | KDM4E 3242/4885P4HB 3618/4885AKR1B1 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.